Measurement of Hormonal Concentration in Chylothorax Fluid in Infants With Congenital Chylothorax

Late onset Hypothyroidism was found in infant with congenital hypothyroidism. The hypothesis is that infants with congenital hypothyroidism may lose thyroxin and other hormones via the chylothorax fluid causing transient hypothyroidism. In this study hormonal concentration will be measured in the chyle as well as hormonal serum level...

Date First Received: December 19, 2005

Last Updated: February 28, 2007

Verified by: Sheba Medical Center, January 2006

Clinical Trial Phase: N/A | Start Date: March 2005

Overall Status: Recruiting

Estimated Enrollment: 15

Brief Summary

Condition Keyword(s):

Late onset Hypothyroidism was found in infant with congenital hypothyroidism. The hypothesis is that infants with congenital hypothyroidism may lose thyroxin and other hormones via the chylothorax fluid causing transient hypothyroidism. In this study hormonal concentration will be measured in the chyle as well as hormonal serum level.

Study Type: Observational

Study Design: Longitudinal, Case Control, Prospective Study

Detailed Clinical Trial Description

Late onset Hypothyroidism was found in infant with congenital hypothyroidism. The hypothesis is that infants with congenital hypothyroidism may lose thyroxin and other hormones via the chylothorax fluid causing transient hypothyroidism. In this study hormonal concentration will be measured in the chyle as well as hormonal serum level.

Criteria for Participation in this Clinical Trial

Inclusion Criteria:

  • Infants with congenital chylothorax requiring thorax drain

Exclusion Criteria:

  • none

Gender Eligibility for this Clinical Trial: Both

Minimum Age for this Clinical Trial: N/A

Maximum Age for this Clinical Trial: 10 Weeks

Are Healthy Volunteers Accepted for this Clinical Trial?: No

Clinical Trial Sponsor Information

Lead Sponsor: Sheba Medical Center

Overall Clinical Trial Officials and Contacts

Jacob Kuint, MD Principal Investigator Sheba Medical Center  

Overall Contact: Jacob Kuint, MD 972-3-5302227 kuint-j@sheba.health.gov.il

Additional Information

Information obtained from ClinicalTrials.gov on October 15, 2008

Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00267345

Study ID Number: SHEBA-05-3927-JK-CTIL

ClinicalTrials.gov Identifier: NCT00267345

Health Authority: Israel: Israeli Health Ministry Pharmaceutical Administration

Clinical Trials Authorship and Review

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.